FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004708926> ?p ?o ?g. }

• W3004708926 endingPage "18" @default.
• W3004708926 startingPage "7" @default.
• W3004708926 abstract "TransCelerate’s Intelligent Automation Opportunities (IAO) in Pharmacovigilance initiative has been working to evaluate various pharmacovigilance processes to facilitate systematic innovation with intelligent automation across the entire area. The individual case safety report (ICSR) process was the first process selected for evaluation because of its resource-intensive nature, risk of errors, and operational inefficiencies. TransCelerate’s IAO in Pharmacovigilance initiative initially worked to articulate an end-to-end ICSR process that would generically apply to various pharmacovigilance organizations, despite organizational variations in specific ICSR process steps. This paper aims to address the need for a systematic review framework for automation of the ICSR process from the value, impact, perceived risk, and opportunity point of view. The generic ICSR process, which starts with receipt of an adverse event report, was grouped into three process blocks: case intake, case processing, and case reporting. Each of these was then further detailed in individual process steps. A total of 19 TransCelerate member companies were invited to complete a survey designed to facilitate understanding of automation opportunities across the ICSR process. Heat maps of the current level of effort, expected benefit of automation, and perceived risk of automation were compiled from responses to identify intelligent automation opportunities for specific ICSR process steps. Relevant experts on the TransCelerate evaluation team analyzed and interpreted the anonymized and aggregated results. In total, 15 TransCelerate member companies responded to the survey and indicated that ICSR process steps with current high effort, expected high automation benefit, low or manageable automation risk, and low levels of current automation present the best opportunities for future automation. Such steps include language translations, case verification, in-line quality control, prioritization/triage, data entry, alerts for cases of interest, workflow management, and monitoring. Some steps (e.g., submission) have been automated for a number of years and appear on the heat map as having low potential for further automation. The survey responses implied that, despite successful use of intelligent automation technologies in other areas, adoption within pharmacovigilance and the ICSR process in particular remains limited. The perceived high risk to patient safety is expected to decrease with additional successful applications in pharmacovigilance. Our results highlight the areas of greatest opportunity for intelligent automation based on the potential benefits of applying intelligent automation and the perceived risks associated with each ICSR process step. Responding TransCelerate member companies already automate many steps to varying degrees. However, a significant opportunity remains for automation to penetrate further. Additionally, the pharmacovigilance industry culture needs to change in order to reduce the perceived risk of automation and to encourage a more progressive approach to intelligent automation. Increased automation is crucial to empower agile and efficient pharmacovigilance." @default.
• W3004708926 created "2020-02-14" @default.
• W3004708926 creator A5013433342 @default.
• W3004708926 creator A5023726705 @default.
• W3004708926 creator A5031239863 @default.
• W3004708926 creator A5059883080 @default.
• W3004708926 creator A5062937178 @default.
• W3004708926 creator A5077706183 @default.
• W3004708926 date "2020-02-01" @default.
• W3004708926 modified "2023-10-01" @default.
• W3004708926 title "Automation Opportunities in Pharmacovigilance: An Industry Survey" @default.
• W3004708926 cites W1791323137 @default.
• W3004708926 cites W2007138823 @default.
• W3004708926 cites W2059039116 @default.
• W3004708926 cites W2165530491 @default.
• W3004708926 cites W2651948199 @default.
• W3004708926 cites W2795290179 @default.
• W3004708926 cites W2803760365 @default.
• W3004708926 cites W2888424632 @default.
• W3004708926 cites W2896962189 @default.
• W3004708926 cites W2897647360 @default.
• W3004708926 cites W2900284063 @default.
• W3004708926 cites W2910998330 @default.
• W3004708926 cites W2933152277 @default.
• W3004708926 cites W2989157027 @default.
• W3004708926 cites W2996894939 @default.
• W3004708926 doi "https://doi.org/10.1007/s40290-019-00320-0" @default.
• W3004708926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32036574" @default.
• W3004708926 hasPublicationYear "2020" @default.
• W3004708926 type Work @default.
• W3004708926 sameAs 3004708926 @default.
• W3004708926 citedByCount "19" @default.
• W3004708926 countsByYear W30047089262020 @default.
• W3004708926 countsByYear W30047089262021 @default.
• W3004708926 countsByYear W30047089262022 @default.
• W3004708926 countsByYear W30047089262023 @default.
• W3004708926 crossrefType "journal-article" @default.
• W3004708926 hasAuthorship W3004708926A5013433342 @default.
• W3004708926 hasAuthorship W3004708926A5023726705 @default.
• W3004708926 hasAuthorship W3004708926A5031239863 @default.
• W3004708926 hasAuthorship W3004708926A5059883080 @default.
• W3004708926 hasAuthorship W3004708926A5062937178 @default.
• W3004708926 hasAuthorship W3004708926A5077706183 @default.
• W3004708926 hasBestOaLocation W30047089261 @default.
• W3004708926 hasConcept C111919701 @default.
• W3004708926 hasConcept C112930515 @default.
• W3004708926 hasConcept C115901376 @default.
• W3004708926 hasConcept C127413603 @default.
• W3004708926 hasConcept C144133560 @default.
• W3004708926 hasConcept C195094911 @default.
• W3004708926 hasConcept C197934379 @default.
• W3004708926 hasConcept C21457203 @default.
• W3004708926 hasConcept C41008148 @default.
• W3004708926 hasConcept C57658597 @default.
• W3004708926 hasConcept C71924100 @default.
• W3004708926 hasConcept C78519656 @default.
• W3004708926 hasConcept C98045186 @default.
• W3004708926 hasConcept C98274493 @default.
• W3004708926 hasConceptScore W3004708926C111919701 @default.
• W3004708926 hasConceptScore W3004708926C112930515 @default.
• W3004708926 hasConceptScore W3004708926C115901376 @default.
• W3004708926 hasConceptScore W3004708926C127413603 @default.
• W3004708926 hasConceptScore W3004708926C144133560 @default.
• W3004708926 hasConceptScore W3004708926C195094911 @default.
• W3004708926 hasConceptScore W3004708926C197934379 @default.
• W3004708926 hasConceptScore W3004708926C21457203 @default.
• W3004708926 hasConceptScore W3004708926C41008148 @default.
• W3004708926 hasConceptScore W3004708926C57658597 @default.
• W3004708926 hasConceptScore W3004708926C71924100 @default.
• W3004708926 hasConceptScore W3004708926C78519656 @default.
• W3004708926 hasConceptScore W3004708926C98045186 @default.
• W3004708926 hasConceptScore W3004708926C98274493 @default.
• W3004708926 hasIssue "1" @default.
• W3004708926 hasLocation W30047089261 @default.
• W3004708926 hasLocation W30047089262 @default.
• W3004708926 hasOpenAccess W3004708926 @default.
• W3004708926 hasPrimaryLocation W30047089261 @default.
• W3004708926 hasRelatedWork W2380555098 @default.
• W3004708926 hasRelatedWork W2801524828 @default.
• W3004708926 hasRelatedWork W2909293663 @default.
• W3004708926 hasRelatedWork W2945955378 @default.
• W3004708926 hasRelatedWork W2997519675 @default.
• W3004708926 hasRelatedWork W3214167544 @default.
• W3004708926 hasRelatedWork W4200433280 @default.
• W3004708926 hasRelatedWork W4281484650 @default.
• W3004708926 hasRelatedWork W4286750075 @default.
• W3004708926 hasRelatedWork W4386321242 @default.
• W3004708926 hasVolume "34" @default.
• W3004708926 isParatext "false" @default.
• W3004708926 isRetracted "false" @default.
• W3004708926 magId "3004708926" @default.
• W3004708926 workType "article" @default.